Yishen Capsule Alleviated Symptoms of Diabetic Nephropathy via NOD-like Receptor Signaling Pathway

References

• Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843. doi:10.1016/j.diabres.2019.107843
   PubMed Web of Science ®Google Scholar
• Samsu N, Bellini MI. Diabetic nephropathy: challenges in pathogenesis, diagnosis, and treatment. Biomed Res Int. 2021;2021:1497449. doi:10.1155/2021/1497449
   PubMed Web of Science ®Google Scholar
• Du X, Liu J, Xue Y, et al. Alteration of gut microbial profile in patients with diabetic nephropathy. Endocrine. 2021;73(1):71–84. doi:10.1007/s12020-021-02721-1
   PubMed Web of Science ®Google Scholar
• Ni L, Yuan C, Wu X, Veljkovic A. Endoplasmic reticulum stress in diabetic nephrology: regulation, pathological role, and therapeutic potential. Oxid Med Cell Longev. 2021;2021:7277966. doi:10.1155/2021/7277966
   Web of Science ®Google Scholar
• Davies MJ, D′Alessio DA, Fradkin J, et al. Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2018;41(12):2669–2701. doi:10.2337/dci18-0033
   PubMed Web of Science ®Google Scholar
• Fang J, Wei H, Sun Y, et al. Regulation of podocalyxin expression in the kidney of streptozotocin-induced diabetic rats with Chinese herbs (Yishen capsule). BMC Complement Altern Med. 2013;13:76. doi:10.1186/1472-6882-13-76
   PubMed Web of Science ®Google Scholar
• Fang J, Li Y. 益肾胶囊对糖尿病肾病大鼠足细胞损伤的影响 [Effect of Yi Shen Jiao Nang on podocytes in renal tissue and urine of rats with diabetic nephropathy]. Chin J Integr Traditional West Nephrol. 2008;1:14–18. Chinese.
   Google Scholar
• Liu Y, Liu W, Zhang Z, et al. Yishen capsule promotes podocyte autophagy through regulating SIRT1/NF-kappaB signaling pathway to improve diabetic nephropathy. Ren Fail. 2021;43(1):128–140. doi:10.1080/0886022X.2020.1869043
   PubMed Web of Science ®Google Scholar
• Hu Y, Liu S, Liu W, et al. Potential molecular mechanism of Yishen Capsule in the treatment of diabetic nephropathy based on network pharmacology and molecular docking. Diabetes Metab Syndr Obes. 2022;15:943–962. doi:10.2147/DMSO.S350062
   Web of Science ®Google Scholar
• Wang S, Jiang H, Liu Q, et al. A comparative study on the traditional versus modern yellow rice wine processing methods using Taohong Siwu Decoction for pharmaceutical production. J Ethnopharmacol. 2022;290:115114. doi:10.1016/j.jep.2022.115114
   Web of Science ®Google Scholar
• Du H, Xiao G, Xue Z, et al. QiShenYiQi ameliorates salt-induced hypertensive nephropathy by balancing ADRA1D and SIK1 expression in Dahl salt-sensitive rats. Biomed Pharmacother. 2021;141:111941. doi:10.1016/j.biopha.2021.111941
   PubMed Web of Science ®Google Scholar
• Hussain Lodhi A, Ahmad FU, Furwa K, et al. Role of oxidative stress and reduced endogenous hydrogen sulfide in diabetic nephropathy. Drug Des Devel Ther. 2021;15:1031–1043. doi:10.2147/DDDT.S291591
   PubMed Web of Science ®Google Scholar
• Shi L, Xiao C, Zhang Y, et al. Vitamin D/vitamin D receptor/Atg16L1 axis maintains podocyte autophagy and survival in diabetic kidney disease. Ren Fail. 2022;44(1):694–705. doi:10.1080/0886022X.2022.2063744
   PubMed Web of Science ®Google Scholar
• Toblli JE, Bevione P, Di Gennaro F, et al. Understanding the mechanisms of proteinuria: therapeutic implications. Int J Nephrol. 2012;2012:546039. doi:10.1155/2012/546039
   PubMedGoogle Scholar
• Liu W, Zhang Z, Liu Y, et al. 益肾胶囊通过上调SIRT1抑制高糖诱导足细胞凋亡的机制研究 [Mechanism of Yishen capsule inhibiting podocyte apoptosis induced by high glucose by raising SIRT1]. Chin J Integr Traditional West Nephrol. 2021;22(6):477–481. Chinese.
   Google Scholar
• Auyeung KK, Han Q, Ko JK. Astragalus membranaceus: a review of its protection against inflammation and gastrointestinal cancers. Am J Chin Med. 2016;44(1):1–12. doi:10.1142/S0192415X16500014
   PubMed Web of Science ®Google Scholar
• Liu P, Zhao H, Luo Y. Anti-aging implications of astragalus membranaceus (Huangqi): a Well-KnownChinese Tonic. Aging Dis. 2017;8(6):868–886. doi:10.14336/AD.2017.0816
   PubMed Web of Science ®Google Scholar
• Zhang Y, Tao C, Xuan C, et al. Transcriptomic analysis reveals the protection of astragaloside iv against diabetic nephropathy by modulating inflammation. Oxid Med Cell Longev. 2020;2020:9542165. doi:10.1155/2020/9542165
   PubMed Web of Science ®Google Scholar
• Wei W, Zeng R, Gu C, et al. Angelica sinensis in China-A review of botanical profile, ethnopharmacology, phytochemistry and chemical analysis. J Ethnopharmacol. 2016;190:116–141. doi:10.1016/j.jep.2016.05.023
   PubMed Web of Science ®Google Scholar
• Kil Y, Pham ST, Seo EK, et al. Angelica keiskei, an emerging medicinal herb with various bioactive constituents and biological activities. Arch Pharm Res. 2017;40(6):655–675. doi:10.1007/s12272-017-0892-3
   PubMed Web of Science ®Google Scholar
• Sui Y, Liu W, Tian W, et al. A branched arabinoglucan from Angelica sinensis ameliorates diabetic renal damage in rats. Phytother Res. 2019;33(3):818–831. doi:10.1002/ptr.6275
   Web of Science ®Google Scholar
• Song CW, Wang SM, Zhou LL, et al. Isolation and identification of compounds responsible for antioxidant capacity of Euryale ferox seeds. J Agric Food Chem. 2011;59(4):1199–1204. doi:10.1021/jf1041933
   PubMed Web of Science ®Google Scholar
• Poon TY, Ong KL, Cheung BM. Review of the effects of the traditional Chinese medicine rehmannia six formula on diabetes mellitus and its complications. J Diabetes. 2011;3(3):184–200. doi:10.1111/j.1753-0407.2011.00130.x
   PubMed Web of Science ®Google Scholar
• Wang ZS, Gao F, Lu FE. Effect of ethanol extract of Rhodiola rosea on the early nephropathy in type 2 diabetic rats. J Huazhong Univ Sci Technolog Med Sci. 2013;33(3):375–378. doi:10.1007/s11596-013-1127-6
   Google Scholar
• Wang S, Zhao X, Yang S, et al. Salidroside alleviates high glucose-induced oxidative stress and extracellular matrix accumulation in rat glomerular mesangial cells by the TXNIP-NLRP3inflammasome pathway. Chem Biol Interact. 2017;278:48–53. doi:10.1016/j.cbi.2017.10.012
   PubMed Web of Science ®Google Scholar
• Lin S, Guo Y, Lv Z. Value analysis of using urinary microalbumin in artificial intelligence medical institutions to detect early renal damage in diabetes. J Healthc Eng. 2021;2021:6678454. doi:10.1155/2021/6678454
   Web of Science ®Google Scholar
• Bahreini E, Rezaei-Chianeh Y, Nabi-Afjadi M. Molecular mechanisms involved in intrarenal renin-angiotensin and alternative pathways in diabetic nephropathy - a review. Rev Diabet Stud. 2021;17(1):1–10. doi:10.1900/RDS.2021.17.1
   Google Scholar
• Tziastoudi M, Stefanidis I. The role of cytokines in diabetic nephropathy. Int J Clin Pract. 2021;75(12):e14959. doi:10.1111/ijcp.14959
   Web of Science ®Google Scholar
• Köppel H, Yard BA, Christ M, et al. Modulation of angiotensin II-mediated signalling by heparan sulphate glycosaminoglycans. Nephrol Dial Transplant. 2003;18(11):2240–2247. doi:10.1093/ndt/gfg376
   Web of Science ®Google Scholar
• Karamian M, Moossavi M, Hemmati M. From diabetes to renal aging: the therapeutic potential of adiponectin. J Physiol Biochem. 2021;77(2):205–214. doi:10.1007/s13105-021-00790-4
   Web of Science ®Google Scholar
• Chen Y, Yang Y, Liu Z, He L. Adiponectin promotes repair of renal tubular epithelial cells by regulating mitochondrial biogenesis and function. Metabolism. 2022;128:154959. doi:10.1016/j.metabol.2021.154959
   PubMed Web of Science ®Google Scholar
• Boniecka I, Jeznach-Steinhagen A, Michalska W, et al. Nutritional status, selected nutrients intake and their relationship with the concentration of ghrelin and adiponectin in patients with diabetic nephropathy. Nutrients. 2021;13(12):4416. doi:10.3390/nu13124416
   Web of Science ®Google Scholar
• Lei Y, Cui Q, Yang G, et al. Statins mitigate stress-related vascular aging and atherosclerosis in apoE-deficient mice fed high fat-diet: the role of glucagon-like peptide-1/adiponectin axis. Front Cell Dev Biol. 2021;9:687868. doi:10.3389/fcell.2021.687868
   PubMed Web of Science ®Google Scholar
• Combs TP, Berg AH, Obici S, et al. Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest. 2001;108(12):1875–1881. doi:10.1172/JCI14120
   PubMed Web of Science ®Google Scholar
• Goodarzi G, Setayesh L, Fadaei R, et al. Circulating levels of asprosin and its association with insulin resistance and renal function in patients with type 2 diabetes mellitus and diabetic nephropathy. Mol Biol Rep. 2021;48(7):5443–5450. doi:10.1007/s11033-021-06551-2
   PubMed Web of Science ®Google Scholar
• Watanabe T, Fujimoto Y, Morimoto A, et al. Development of fully automated and ultrasensitive assays for urinary adiponectin and their application as novel biomarkers for diabetic kidney disease. Sci Rep. 2020;10(1):15869. doi:10.1038/s41598-020-72494-6
   Web of Science ®Google Scholar
• Zhang Z, Ni L, Zhang L, et al. Empagliflozin regulates the AdipoR1/p-AMPK/p-ACC pathway to alleviate lipid deposition in diabetic nephropathy. Diabetes Metab Syndr Obes. 2021;14:227–240. doi:10.2147/DMSO.S289712
   PubMed Web of Science ®Google Scholar
• Zoja C, Xinaris C, Macconi D. Diabetic nephropathy: novel molecular mechanisms and therapeutic targets. Front Pharmacol. 2020;11:586892. doi:10.3389/fphar.2020.586892
   PubMed Web of Science ®Google Scholar
• Benedetti V, Lavecchia AM, Locatelli M, et al. Alteration of thyroid hormone signaling triggers the diabetes-induced pathological growth, remodeling, and dedifferentiation of podocytes. JCI Insight. 2019;4(18):e130249. doi:10.1172/jci.insight.130249
   Web of Science ®Google Scholar
• Navarro JF, Mora C. Role of inflammation in diabetic complications. Nephrol Dial Transplant. 2005;20(12):2601–2604. doi:10.1093/ndt/gfi155
   PubMed Web of Science ®Google Scholar
• Yiu WH, Wong DW, Wu HJ, et al. Kallistatin protects against diabetic nephropathy in db/db mice by suppressing AGE-RAGE induced oxidative stress. Kidney Int. 2016;89(2):386–398. doi:10.1038/ki.2015.331
   Web of Science ®Google Scholar
• Zhang H, Nair V, Saha J, et al. Podocyte specific JAK2 overexpression worsens diabetic kidney disease in mice. Kidney Int. 2017;92(4):909–921. doi:10.1016/j.kint.2017.03.027
   PubMed Web of Science ®Google Scholar
• Yaribeygi H, Atkin SL, Sahebkar A. Interleukin-18 and diabetic nephropathy: a review. J Cell Physiol. 2019;234(5):5674–5682. doi:10.1002/jcp.27427
   PubMed Web of Science ®Google Scholar
• Araújo LS, Torquato BGS, da Silva CA, et al. Renal expression of cytokines and chemokines in diabetic nephropathy. BMC Nephrol. 2020;21(1):308. doi:10.1186/s12882-020-01960-0
   PubMed Web of Science ®Google Scholar
• Li MX, Zhao YF, Qiao HX, et al. CXCR3 knockdown protects against high glucose-induced podocyte apoptosis and inflammatory cytokine production at the onset of diabetic nephropathy. Int J Clin Exp Pathol. 2017;10(8):8829–8838.
   Web of Science ®Google Scholar
• Siddiqui K, Joy SS, Al-Rubeaan K. Association of urinary monocyte chemoattractant protein-1 (MCP-1) and kidney injury molecule-1 (KIM-1) with risk factors of diabetic kidney disease in type 2 diabetes patients. Int Urol Nephrol. 2019;51(8):1379–1386. doi:10.1007/s11255-019-02201-6
   Web of Science ®Google Scholar
• Zhang C, Boini KM, Xia M, et al. Activation of Nod-like receptor protein 3 inflammasomes turns on podocyte injury and glomerular sclerosis in hyperhomocysteinemia. Hypertension. 2012;60(1):154–162. doi:10.1161/HYPERTENSIONAHA.111.189688
   PubMed Web of Science ®Google Scholar
• Sayan M, Mossman BT. The NLRP3 inflammasome in pathogenic particle and fibre-associated lung inflammation and diseases. Part Fibre Toxicol. 2016;13(1):51. doi:10.1186/s12989-016-0162-4
   PubMed Web of Science ®Google Scholar
• Yaribeygi H, Katsiki N, Butler AE, et al. Effects of antidiabetic drugs on NLRP3 inflammasome activity, with a focus on diabetic kidneys. Drug Discov Today. 2019;24(1):256–262. doi:10.1016/j.drudis.2018.08.005
   PubMed Web of Science ®Google Scholar
• Ising C, Venegas C, Zhang S, et al. NLRP3 inflammasome activation drives tau pathology. Nature. 2019;575(7784):669–673. doi:10.1038/s41586-019-1769-z
   PubMed Web of Science ®Google Scholar
• Zhang Y, Dong Z, Song W. NLRP3 inflammasome as a novel therapeutic target for Alzheimer’s disease. Signal Transduct Target Ther. 2020;5(1):37. doi:10.1038/s41392-020-0145-7
   PubMed Web of Science ®Google Scholar
• Paramel Varghese G, Folkersen L, Strawbridge RJ, et al. NLRP3 inflammasome expression and activation in human atherosclerosis. J Am Heart Assoc. 2016;5(5):e003031. doi:10.1161/JAHA.115.003031
   Web of Science ®Google Scholar
• Wang W, Pang J, Ha EH, et al. Development of novel NLRP3-XOD dual inhibitors for the treatment of gout. Bioorg Med Chem Lett. 2020;30(4):126944. doi:10.1016/j.bmcl.2019.126944
   Web of Science ®Google Scholar
• Kazemi F. Myostatin alters with exercise training in diabetic rats; possible interaction with glycosylated hemoglobin and inflammatory cytokines. Cytokine. 2019;120:99–106. doi:10.1016/j.cyto.2019.04.012
   PubMed Web of Science ®Google Scholar
• Yi H, Peng R, Zhang LY, et al. LincRNA-Gm4419 knockdown ameliorates NF-kappaB/NLRP3 inflammasome mediated inflammation in diabetic nephropathy. Cell Death Dis. 2017;8(2):e2583. doi:10.1038/cddis.2016.451
   PubMed Web of Science ®Google Scholar
• Wang S, Li Y, Fan J, et al. Interleukin-22 ameliorated renal injury and fibrosis in diabetic nephropathy through inhibition of NLRP3 inflammasome activation. Cell Death Dis. 2017;8(7):e2937. doi:10.1038/cddis.2017.292
   Web of Science ®Google Scholar
• Fu Y, Wu N, Zhao D. Function of NLRP3 in the pathogenesis and development of diabetic nephropathy. Med Sci Monit. 2017;23:3878–3884. doi:10.12659/MSM.903269
   PubMed Web of Science ®Google Scholar
• Lin J, Cheng A, Cheng K, et al. New Insights into the mechanisms of pyroptosis and implications for diabetic kidney disease. Int J Mol Sci. 2020;21(19):7057. doi: 10.3390/ijms21197057
   PubMed Web of Science ®Google Scholar
• Sun Z, Ma Y, Chen F, et al. Artesunate ameliorates high glucose-induced rat glomerular mesangial cell injury by suppressing the TLR4/NF-κB/NLRP3 inflammasome pathway. Chem Biol Interact. 2018;293:11–19. doi:10.1016/j.cbi.2018.07.011
   PubMed Web of Science ®Google Scholar